- Home
- STRO vs SKYH Comparison
STRO vs SKYH Comparison
Compare STRO & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SKYH
- Stock Information
- Founded
- STRO 2003
- SKYH 2017
- Country
- STRO United States
- SKYH United States
- Employees
- STRO N/A
- SKYH N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SKYH Military/Government/Technical
- Sector
- STRO Health Care
- SKYH Industrials
- Exchange
- STRO Nasdaq
- SKYH Nasdaq
- Market Cap
- STRO 77.7M
- SKYH 325.2M
- IPO Year
- STRO 2018
- SKYH N/A
- Fundamental
- Price
- STRO $0.75
- SKYH $9.98
- Analyst Decision
- STRO Hold
- SKYH Strong Buy
- Analyst Count
- STRO 7
- SKYH 3
- Target Price
- STRO $3.97
- SKYH $14.83
- AVG Volume (30 Days)
- STRO 1.2M
- SKYH 170.3K
- Earning Date
- STRO 08-12-2025
- SKYH 08-12-2025
- Dividend Yield
- STRO N/A
- SKYH N/A
- EPS Growth
- STRO N/A
- SKYH N/A
- EPS
- STRO N/A
- SKYH N/A
- Revenue
- STRO $66,434,000.00
- SKYH $17,950,000.00
- Revenue This Year
- STRO N/A
- SKYH $122.85
- Revenue Next Year
- STRO N/A
- SKYH $45.30
- P/E Ratio
- STRO N/A
- SKYH N/A
- Revenue Growth
- STRO N/A
- SKYH 102.32
- 52 Week Low
- STRO $0.52
- SKYH $8.26
- 52 Week High
- STRO $5.17
- SKYH $14.52
- Technical
- Relative Strength Index (RSI)
- STRO 44.48
- SKYH 53.76
- Support Level
- STRO $0.73
- SKYH $9.94
- Resistance Level
- STRO $0.79
- SKYH $10.28
- Average True Range (ATR)
- STRO 0.06
- SKYH 0.29
- MACD
- STRO 0.00
- SKYH 0.10
- Stochastic Oscillator
- STRO 40.20
- SKYH 66.97
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.